Abbott’s diabetes care VP joins Insulet
This article was originally published in Clinica
Executive Summary
Insulet, developer of the OmniPod tubing-free insulin management system, has appointed Peter Devlin as chief commercial officer. Mr Devlin will be responsible for the Bedford, Massachusetts firm’s sales and marketing, business development, clinical research and customer care functions. Prior to joining Insulet, he was divisional vice-president of global strategic marketing for Abbott Lab’s diabetes care business.